NCT02857062View on ClinicalTrials.gov

To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 23, 2016

Primary Completion Date

February 2, 2017

Study Completion Date

February 2, 2017

Conditions
Atopic Dermatitis / Eczema
Interventions
DEVICE

E45 Eczema Repair Emollient

E45 Eczema Repair Emollient

Sponsors

Collaborators (1)

Intertek
All Listed Sponsors
collaborator

Intertek

INDUSTRY

lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY

NCT02857062 - To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin | Biotech Hunter | Biotech Hunter